Jun 8, 2020

A new immunotherapeutic agent for children and adolescents with advanced lymphoma

It establishes a new standard treatment with an improved cure rate for children with advanced non-Hodgkin lymphoma, mainly Burkitt lymphoma.

Innovative surgery preserves limb growth for childhood bone cancer patients

CAR-T Cell Therapy Shows EFS Benefit in Pediatric Leukemia Subset

Global clinical trial shows improved survival rates for common childhood leukemia

More than half of children with cancer die in the hospital

A new CHOP research program is exploring ways to reduce long-term effects of cancer treatment

The ticking ‘epigenetic’ clock measures true biological age

Serum protein panel test can help identify cardiomyopathy risk in childhood cancer survivors

UCalgary researchers help preserve future fertility options for children impacted by cancer

How a Penn State professor developed a cancer-fighting drug for kids

New insights into risk assessment of rare, aggressive tumors in children